{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:06:26Z","timestamp":1794542786643,"version":"4.9.1"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 877"],"award-info":[{"award-number":["SFB 877"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["125440785 \\u2013 SFB 877"],"award-info":[{"award-number":["125440785 \\u2013 SFB 877"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["A14"],"award-info":[{"award-number":["A14"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.cytogfr.2021.04.002","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T01:15:49Z","timestamp":1619226949000},"page":"18-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["The cytokine interleukin-11 crucially links bone formation, remodeling and resorption"],"prefix":"10.1016","volume":"60","author":[{"given":"Birte","family":"Kespohl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Schumertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9511-4999","authenticated-orcid":false,"given":"Jessica","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Lokau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4939-6950","authenticated-orcid":false,"given":"Christoph","family":"Garbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2021.04.002_bib0005","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","DOI":"10.1007\/164_2019_346","article-title":"Cytokines and bone: osteoimmunology","author":"Lorenzo","year":"2020"},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0010","article-title":"The cells of bone and their interactions","author":"Ansari","year":"2020","journal-title":"Handb. Exp. Pharmacol."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.04.002_bib0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41580-020-00279-w","article-title":"Mechanisms of bone development and repair","volume":"21","author":"Salhotra","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cytogfr.2012.04.001","article-title":"Plasticity and cross-talk of interleukin 6-type cytokines","volume":"23","author":"Garbers","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.04.002_bib0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ajhg.2011.05.024","article-title":"Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth","volume":"89","author":"Nieminen","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.04.002_bib0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/mgg3.28","article-title":"Mutations in the interleukin receptor IL11RA cause autosomal recessive crouzon-like craniosynostosis","volume":"1","author":"Keupp","year":"2013","journal-title":"Mol. Genet. Genomic Med."},{"issue":"3\u20134","key":"10.1016\/j.cytogfr.2021.04.002_bib0035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/cge.13409","article-title":"IL11RA-related Crouzon-like autosomal recessive craniosynostosis in 10 new patients: resemblances and differences","volume":"94","author":"Brischoux-Boucher","year":"2018","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.04.002_bib0040","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ajmg.a.38540","article-title":"Single suture craniosynostosis: identification of rare variants in genes associated with syndromic forms","volume":"176","author":"Clarke","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.04.002_bib0045","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ajmg.a.61070","article-title":"Evolution of the phenotype of craniosynostosis with dental anomalies syndrome and report of IL11RA variant population frequencies in a Crouzon-like autosomal recessive syndrome","volume":"179","author":"Korakavi","year":"2019","journal-title":"Am. J. Med. Genet. A"},{"issue":"5","key":"10.1016\/j.cytogfr.2021.04.002_bib0050","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1469-7580.2005.00475.x","article-title":"Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies","volume":"207","author":"Morriss\u2010Kay","year":"2005","journal-title":"J. Anat."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0055","first-page":"585","article-title":"The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor","volume":"12","author":"Nandurkar","year":"1996","journal-title":"Oncogene"},{"issue":"46","key":"10.1016\/j.cytogfr.2021.04.002_bib0060","doi-asserted-by":"crossref","first-page":"36197","DOI":"10.1074\/jbc.M004648200","article-title":"Interleukin-11 signals through the formation of a hexameric receptor complex","volume":"275","author":"Barton","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.04.002_bib0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cytogfr.2015.07.004","article-title":"Interleukin-6: biology, signaling and strategies of blockade","volume":"26","author":"Schaper","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.04.002_bib0070","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1073\/pnas.1620290114","article-title":"YAP-IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesis","volume":"114","author":"Taniguchi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7541","key":"10.1016\/j.cytogfr.2021.04.002_bib0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14228","article-title":"A gp130-Src-YAP module links inflammation to epithelial regeneration","volume":"519","author":"Taniguchi","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.cytogfr.2021.04.002_bib0080","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.celrep.2016.01.053","article-title":"Proteolytic cleavage governs interleukin-11 trans-signaling","volume":"14","author":"Lokau","year":"2016","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.04.002_bib0085","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1182\/blood.V90.11.4403","article-title":"Recombinant soluble interleukin-11 (IL-11) receptor alpha-chain can act as an IL-11 antagonist","volume":"90","author":"Curtis","year":"1997","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.cytogfr.2021.04.002_bib0090","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1074\/jbc.RA118.001879","article-title":"The length of the interleukin-11 receptor stalk determines its capacity for classic signaling","volume":"293","author":"Lokau","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.cytogfr.2021.04.002_bib0095","doi-asserted-by":"crossref","first-page":"14756","DOI":"10.1074\/jbc.M113.466169","article-title":"Minimal interleukin (IL-)6 receptor stalk composition for IL-6R shedding and IL-6 classic signaling","volume":"288","author":"Baran","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biochi.2015.11.005","article-title":"Modular organization of interleukin-6 and interleukin-11 \u03b1-receptors","volume":"119","author":"Nitz","year":"2015","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.04.002_bib0105","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.celrep.2016.06.062","article-title":"Transcytosis of IL-11 and apical redirection of gp130 is mediated by IL-11alpha receptor","volume":"16","author":"Monhasery","year":"2016","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.04.002_bib0110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.bbrc.2017.07.106","article-title":"Cleavage of the interleukin -11 receptor induces processing of its C-terminal fragments by the gamma-secretase and the proteasome","volume":"491","author":"Lokau","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"15","key":"10.1016\/j.cytogfr.2021.04.002_bib0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153677","article-title":"Differences in shedding of the interleukin -11 receptor by the proteases ADAM9, ADAM10, ADAM17, meprin alpha, meprin beta and MT1-MMP","volume":"20","author":"Sammel","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0120","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002087R","article-title":"Interleukin-11 (IL-11) receptor cleavage by the rhomboid protease RHBDL2 induces IL-11 trans-signaling","volume":"35","author":"Koch","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/bj3180489","article-title":"Mediation of interleukin-11-dependent biological responses by a soluble form of the interleukin-11 receptor","volume":"318","author":"Karow","year":"1996","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.04.002_bib0130","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1359\/JBMR.050209","article-title":"Interleukin-11 receptor signaling is required for normal bone remodeling","volume":"20","author":"Sims","year":"2005","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.04.002_bib0135","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jcb.20958","article-title":"Regulation of osteoblast differentiation by transcription factors","volume":"99","author":"Komori","year":"2006","journal-title":"J. Cell. Biochem."},{"issue":"14","key":"10.1016\/j.cytogfr.2021.04.002_bib0140","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1039\/B402005G","article-title":"Structure and mechanical quality of the collagen\u2013mineral nano-composite in bone","volume":"14","author":"Fratzl","year":"2004","journal-title":"J. Mater. Chem."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.04.002_bib0145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/dvdy.20603","article-title":"Buried alive: how osteoblasts become osteocytes","volume":"235","author":"Franz-Odendaal","year":"2006","journal-title":"Dev. Dyn."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.04.002_bib0150","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","article-title":"The osteocyte: an endocrine cell \u2026 and more","volume":"34","author":"Dallas","year":"2013","journal-title":"Endocr. Rev."},{"issue":"12","key":"10.1016\/j.cytogfr.2021.04.002_bib0155","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1002\/jbmr.490","article-title":"Lineage-committed osteoclast precursors circulate in blood and settle down into bone","volume":"26","author":"Muto","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.04.002_bib0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11154-014-9308-6","article-title":"RANKL\/OPG; critical role in bone physiology","volume":"16","author":"Martin","year":"2015","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"7","key":"10.1016\/j.cytogfr.2021.04.002_bib0165","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.0105-2896.2005.00331.x","article-title":"alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology","volume":"208","author":"Ross","year":"2005","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.04.002_bib0175","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/jemt.10374","article-title":"Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities","volume":"61","author":"Delaisse","year":"2003","journal-title":"Microsc. Res. Tech."},{"issue":"4920","key":"10.1016\/j.cytogfr.2021.04.002_bib0180","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1126\/science.2528207","article-title":"Osteoclastic bone resorption by a polarized vacuolar proton pump","volume":"245","author":"Blair","year":"1989","journal-title":"Science (New York, N.Y.)"},{"issue":"5310","key":"10.1016\/j.cytogfr.2021.04.002_bib0185","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1126\/science.276.5310.270","article-title":"Removal of osteoclast bone resorption products by transcytosis","volume":"276","author":"Salo","year":"1997","journal-title":"Science (New York, N.Y.)"},{"issue":"5310","key":"10.1016\/j.cytogfr.2021.04.002_bib0190","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1126\/science.276.5310.266","article-title":"Trafficking of matrix collagens through bone-resorbing osteoclasts","volume":"276","author":"Nesbitt","year":"1997","journal-title":"Science (New York, N.Y.)"},{"issue":"6","key":"10.1016\/j.cytogfr.2021.04.002_bib0195","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1084\/jem.183.6.2581","article-title":"The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures","volume":"183","author":"Romas","year":"1996","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0200","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1210\/en.2003-0839","article-title":"Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitro","volume":"145","author":"Shin","year":"2004","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.cytogfr.2021.04.002_bib0205","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/jbmr.2159","article-title":"The primary function of gp130 signaling in osteoblasts is to maintain bone formation and strength, rather than promote osteoclast formation","volume":"29","author":"Johnson","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.04.002_bib0210","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/endo.139.11.6433","article-title":"Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells","volume":"139","author":"Horwood","year":"1998","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.04.002_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(02)00915-8","article-title":"Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism","volume":"32","author":"Kudo","year":"2003","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.04.002_bib0220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12016-015-8523-6","article-title":"Non-canonical (RANKL-Independent) pathways of osteoclast differentiation and their role in musculoskeletal diseases","volume":"51","author":"Sabokbar","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2407-13-16","article-title":"IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells","volume":"13","author":"McCoy","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0230","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bone.2015.08.005","article-title":"Glycoprotein130 (Gp130)\/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone","volume":"81","author":"Johnson","year":"2015","journal-title":"Bone"},{"issue":"50","key":"10.1016\/j.cytogfr.2021.04.002_bib0235","doi-asserted-by":"crossref","first-page":"49011","DOI":"10.1074\/jbc.M207804200","article-title":"Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice","volume":"277","author":"Takeuchi","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0240","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.bbamcr.2017.12.003","article-title":"The SNP rs4252548 (R112H) which is associated with reduced human height compromises the stability of IL-11","volume":"1865","author":"Lokau","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.04.002_bib0245","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajhg.2010.11.007","article-title":"Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height","volume":"88","author":"Lanktree","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"7640","key":"10.1016\/j.cytogfr.2021.04.002_bib0250","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature21039","article-title":"Rare and low-frequency coding variants alter human adult height","volume":"542","author":"Marouli","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cytogfr.2021.04.002_bib0255","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/107999004323142204","article-title":"Synergism between interleukin-11 and bone morphogenetic protein-2 in the healing of segmental bone defects in a rabbit model","volume":"24","author":"Suga","year":"2004","journal-title":"J. Interferon Cytokine Res."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.04.002_bib0260","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bone.2009.10.009","article-title":"Temporal pattern of gene expression and histology of stress fracture healing","volume":"46","author":"Kidd","year":"2010","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.04.002_bib0265","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9010047","article-title":"Inflammatory profile and osteogenic potential of fracture haematoma in humans","volume":"9","author":"Pountos","year":"2019","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.04.002_bib0270","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.bone.2009.07.087","article-title":"Mechanical stress induces interleukin-11 expression to stimulate osteoblast differentiation","volume":"45","author":"Kido","year":"2009","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.cytogfr.2021.04.002_bib0275","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028415","article-title":"Interleukin-6 family cytokines","volume":"10","author":"Rose-John","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.04.002_bib0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cytogfr.2008.11.004","article-title":"The dual role of IL-6-type cytokines on bone remodeling and bone tumors","volume":"20","author":"Blanchard","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0285","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.biocel.2016.08.003","article-title":"Cell-specific paracrine actions of IL-6 family cytokines from bone, marrow and muscle that control bone formation and resorption","volume":"79","author":"Sims","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.04.002_bib0290","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1515\/hsz-2013-0166","article-title":"Interleukin-6 and interleukin-11: same same but different","volume":"394","author":"Garbers","year":"2013","journal-title":"Biol. Chem."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.04.002_bib0295","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.4049\/jimmunol.169.6.3353","article-title":"IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae","volume":"169","author":"Palmqvist","year":"2002","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.04.002_bib0300","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1006\/cyto.1999.0635","article-title":"Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone","volume":"12","author":"Richards","year":"2000","journal-title":"Cytokine"},{"issue":"17","key":"10.1016\/j.cytogfr.2021.04.002_bib0305","doi-asserted-by":"crossref","first-page":"11535","DOI":"10.1074\/jbc.M607999200","article-title":"Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappaB signaling pathways","volume":"283","author":"Yoshitake","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cytogfr.2021.04.002_bib0310","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/endo.138.9.5364","article-title":"Activation of the Janus kinase\/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation","volume":"138","author":"Bellido","year":"1997","journal-title":"Endocrinology"},{"issue":"24","key":"10.1016\/j.cytogfr.2021.04.002_bib0315","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","article-title":"Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6","volume":"90","author":"Tamura","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"19","key":"10.1016\/j.cytogfr.2021.04.002_bib0320","doi-asserted-by":"crossref","first-page":"7850","DOI":"10.1074\/jbc.RA119.008074","article-title":"IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis","volume":"294","author":"McGregor","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0325","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/endo.132.3.8440191","article-title":"The effect of leukemia inhibitory factor on bone in vivo","volume":"132","author":"Cornish","year":"1993","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.cytogfr.2021.04.002_bib0330","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1172\/JCI40568","article-title":"Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice","volume":"120","author":"Walker","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.cytogfr.2021.04.002_bib0335","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1359\/jbmr.080706","article-title":"Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling","volume":"23","author":"Walker","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.04.002_bib0340","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/j.1460-2075.1994.tb06368.x","article-title":"Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion","volume":"13","author":"Poli","year":"1994","journal-title":"EMBO J."},{"issue":"11","key":"10.1016\/j.cytogfr.2021.04.002_bib0345","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/art.22175","article-title":"Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system","volume":"54","author":"De Benedetti","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0350","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fendo.2015.00041","article-title":"Coupling signals between the osteoclast and osteoblast: how are messages transmitted between these temporary visitors to the bone surface?","volume":"6","author":"Sims","year":"2015","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"8","key":"10.1016\/j.cytogfr.2021.04.002_bib0355","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.17219\/acem\/68739","article-title":"Sclerostin: Intracellular mechanisms of action and its role in the pathogenesis of skeletal and vascular disorders","volume":"26","author":"Pietrzyk","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"issue":"20","key":"10.1016\/j.cytogfr.2021.04.002_bib0360","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.04.002_bib0365","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bone.2005.01.007","article-title":"Gene array analysis of Wnt-regulated genes in C3H10T1\/2 cells","volume":"36","author":"Jackson","year":"2005","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.cytogfr.2021.04.002_bib0370","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1074\/jbc.M110.178251","article-title":"Zinc finger protein 467 is a novel regulator of osteoblast and adipocyte commitment","volume":"286","author":"Quach","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.04.002_bib0375","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood.V82.5.1428.1428","article-title":"Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in human long-term marrow cultures","volume":"82","author":"Keller","year":"1993","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0380","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jbmr.1485","article-title":"Contrasting roles of leukemia inhibitory factor in murine bone development and remodeling involve region-specific changes in vascularization","volume":"27","author":"Poulton","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.cytogfr.2021.04.002_bib0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116209","article-title":"Oncostatin M maintains the hematopoietic microenvironment in the bone marrow by modulating adipogenesis and osteogenesis","volume":"9","author":"Sato","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cytogfr.2021.04.002_bib0390","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1242\/dev.121.5.1283","article-title":"Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death","volume":"121","author":"Ware","year":"1995","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.04.002_bib0395","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/endo.137.4.8625883","article-title":"Oncostatin-M: a new bone active cytokine that activates osteoblasts and inhibits bone resorption","volume":"137","author":"Jay","year":"1996","journal-title":"Endocrinology"},{"issue":"24","key":"10.1016\/j.cytogfr.2021.04.002_bib0400","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.83.24.9739","article-title":"Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells","volume":"83","author":"Zarling","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"18","key":"10.1016\/j.cytogfr.2021.04.002_bib0405","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1074\/jbc.271.18.10984","article-title":"Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction","volume":"271","author":"Greenfield","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.04.002_bib0410","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1086\/381715","article-title":"Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann\/Schwartz-Jampel type 2 syndrome","volume":"74","author":"Dagoneau","year":"2004","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0415","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191306","article-title":"Absence of GP130 cytokine receptor signaling causes extended Stuve-Wiedemann syndrome","volume":"217","author":"Chen","year":"2020","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0420","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1210\/endo-126-3-1416","article-title":"Leukemia inhibitory factor: a novel bone-active cytokine","volume":"126","author":"Reid","year":"1990","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.cytogfr.2021.04.002_bib0425","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/1043-4666(90)90027-Q","article-title":"Leukemia inhibitory factor (LIF) inhibits basal bone resorption in fetal rat long bone cultures","volume":"2","author":"Lorenzo","year":"1990","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0430","doi-asserted-by":"crossref","DOI":"10.1096\/fj.03-1259fje","article-title":"Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity","author":"Hiscock","year":"2004","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0435","doi-asserted-by":"crossref","first-page":"E504","DOI":"10.1152\/ajpendo.00520.2010","article-title":"Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth","volume":"301","author":"Hojman","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0440","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bone.2014.03.053","article-title":"Myokines (muscle-derived cytokines and chemokines) including ciliary neurotrophic factor (CNTF) inhibit osteoblast differentiation","volume":"64","author":"Johnson","year":"2014","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.cytogfr.2021.04.002_bib0445","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.yexcr.2009.11.022","article-title":"Leukemia inhibitory factor-dependent increase in myoblast cell number is associated with phosphotidylinositol 3-kinase-mediated inhibition of apoptosis and not mitosis","volume":"316","author":"Hunt","year":"2010","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0450","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00223-010-9337-4","article-title":"Ciliary neurotrophic factor inhibits bone formation and plays a sex-specific role in bone growth and remodeling","volume":"86","author":"McGregor","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0455","first-page":"1","article-title":"Epidemiology of craniosynostosis in Norway","author":"T\u00f8nne","year":"2020","journal-title":"J. Neurosurg. Pediatr."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0460","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.spen.2007.08.008","article-title":"Genetics of craniosynostosis","volume":"14","author":"Kimonis","year":"2007","journal-title":"Semin. Pediatr. Neurol."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.04.002_bib0465","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/jmedgenet-2016-104215","article-title":"Diagnostic value of exome and whole genome sequencing in craniosynostosis","volume":"54","author":"Miller","year":"2017","journal-title":"J. Med. Genet."},{"issue":"10","key":"10.1016\/j.cytogfr.2021.04.002_bib0470","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/hmg\/6.10.1647","article-title":"Craniosynostosis: genes and mechanisms","volume":"6","author":"Wilkie","year":"1997","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.cytogfr.2021.04.002_bib0475","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1227\/00006123-198001000-00005","article-title":"Intrauterine constraint and craniosynostosis","volume":"6","author":"Higginbottom","year":"1980","journal-title":"Neurosurgery"},{"issue":"7","key":"10.1016\/j.cytogfr.2021.04.002_bib0480","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1097\/00006534-200006000-00017","article-title":"Growth restriction of cranial sutures in the fetal lamb causes deformational changes, not craniosynostosis","volume":"105","author":"Bradley","year":"2000","journal-title":"Plast. Reconstr. Surg."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0485","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.SCS.0000157078.53871.11","article-title":"Apert and Crouzon syndromes: clinical findings, genes and extracellular matrix","volume":"16","author":"Carinci","year":"2005","journal-title":"J. Craniofac. Surg."},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0490","first-page":"545","article-title":"Dysostose cranio-faciale hereditair","volume":"33","author":"Crouzon","year":"1912","journal-title":"Bull. Mem. Soc. Med. Hop. Paris"},{"issue":"1","key":"10.1016\/j.cytogfr.2021.04.002_bib0495","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.celrep.2018.09.005","article-title":"Mutations in craniosynostosis patients cause defective interleukin-11 receptor maturation and drive craniosynostosis-like disease in mice","volume":"25","author":"Agthe","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0500","series-title":"Encyclopedia of Food Sciences and Nutrition","first-page":"557","article-title":"BONE","author":"Cashman","year":"2003"},{"issue":"6","key":"10.1016\/j.cytogfr.2021.04.002_bib0505","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S8756-3282(97)00182-8","article-title":"Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development","volume":"21","author":"Rice","year":"1997","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.cytogfr.2021.04.002_bib0510","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191804","article-title":"Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome","volume":"217","author":"Beziat","year":"2020","journal-title":"J. Exp. Med."},{"issue":"16","key":"10.1016\/j.cytogfr.2021.04.002_bib0515","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"7157","key":"10.1016\/j.cytogfr.2021.04.002_bib0520","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.cytogfr.2021.04.002_bib0525","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1084\/jem.20161810","article-title":"A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis","volume":"214","author":"Schwerd","year":"2017","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0530","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3324\/haematol.2018.194233","article-title":"Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function","volume":"104","author":"Shahin","year":"2019","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.cytogfr.2021.04.002_bib0535","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199903043400904","article-title":"Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder","volume":"340","author":"Grimbacher","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cytogfr.2021.04.002_bib0540","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/BF00441793","article-title":"Craniosynostosis in hyper-IgE-syndrome","volume":"144","author":"H\u00f6ger","year":"1985","journal-title":"Eur. J. Pediatr."},{"issue":"8068","key":"10.1016\/j.cytogfr.2021.04.002_bib0545","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0140-6736(78)93028-3","article-title":"Cranial synostosis in Job\u2019s syndrome","volume":"1","author":"Smithwick","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0550","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41413-020-0098-z","article-title":"A variant in IL6ST with a selective IL-11 signaling defect in human and mouse","volume":"8","author":"Schwerd","year":"2020","journal-title":"Bone Res."},{"issue":"6","key":"10.1016\/j.cytogfr.2021.04.002_bib0555","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrd.2018.45","article-title":"Interleukin-6: designing specific therapeutics for a complex cytokine","volume":"17","author":"Garbers","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.cytogfr.2021.04.002_bib0560","first-page":"1727","article-title":"STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice","volume":"118","author":"Ernst","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.cytogfr.2021.04.002_bib0565","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2013.06.017","article-title":"Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can Be targeted therapeutically","volume":"24","author":"Putoczki","year":"2013","journal-title":"Cancer Cell"},{"issue":"7683","key":"10.1016\/j.cytogfr.2021.04.002_bib0570","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature24676","article-title":"IL11 is a crucial determinant of cardiovascular fibrosis","volume":"552","author":"Schafer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0575","article-title":"Therapeutic targeting of interleukin-11 signalling reduces pressure overload-induced cardiac fibrosis in mice","author":"Corden","year":"2020","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"511","key":"10.1016\/j.cytogfr.2021.04.002_bib0580","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw1237","article-title":"Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis","volume":"11","author":"Ng","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0585","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/j.gastro.2019.05.002","article-title":"Inhibiting interleukin 11 signaling reduces hepatocyte death and liver fibrosis, inflammation, and steatosis in mouse models of nonalcoholic steatohepatitis","volume":"157","author":"Widjaja","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cytogfr.2021.04.002_bib0590","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nm0398-303","article-title":"Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation","volume":"4","author":"Robb","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2021.04.002_bib0595","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.placenta.2017.05.015","article-title":"Interleukin-11 classic but not trans-signaling is essential for fertility in mice","volume":"57","author":"Agthe","year":"2017","journal-title":"Placenta"},{"issue":"14","key":"10.1016\/j.cytogfr.2021.04.002_bib0600","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1101\/gad.12.14.2234","article-title":"Maternal IL-11Ralpha function is required for normal decidua and fetoplacental development in mice","volume":"12","author":"Bilinski","year":"1998","journal-title":"Genes Dev."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610121000411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610121000411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:42:44Z","timestamp":1778802164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610121000411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":120,"alternative-id":["S1359610121000411"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2021.04.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cytokine interleukin-11 crucially links bone formation, remodeling and resorption","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2021.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}